Veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in patients with : randomized phase II studyBRCA1/2: randomized phase II study locally recurrent/metastatic breast cancer: randomized phase II study

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles